HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
about
Hallmarks of cancer and AU-rich elementsFolate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migrationSilencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.Matrix metalloproteinases: their functional role in lung cancer.HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.TNF-α promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts.Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.AMD3100 inhibits brain-specific metastasis in lung cancer via suppressing the SDF-1/CXCR4 axis and protecting blood-brain barrier.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.RNA binding protein HuR promotes osteosarcoma cell progression via suppressing the miR-142-3p/HMGA1 axis.Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients
P2860
Q26744134-A1A633E6-E656-419A-AA45-3876528ACCA3Q28829561-E381FD39-CFC2-4A01-A174-951EA79ADB49Q38713758-BACD00CC-155B-4194-8A95-237361A0C98FQ38751031-B281D18E-46E3-4F9D-B86E-A2C9FA7F1CADQ38808628-410AC4E7-3E43-4451-9DBA-3AB6A83CEBE1Q39388493-B76249F5-C2F2-43F0-A8DE-E0827EB60B23Q40064209-7E97BF63-AA40-496D-90E7-71130DB91C42Q40176991-C8264A7F-8255-475C-9756-4E08D7F71F34Q41520357-8BCA427D-0AAB-4890-8DE9-A0D3C6CE319FQ45870196-2C0CA1EC-7194-406F-8A98-9B6F66FC5C8BQ47220856-462DFB45-D220-4D72-A30A-1565990A8854Q47850217-49829A4F-BB98-461D-97FC-CB3DB51D7750Q48596179-5A34D5D9-FAC0-48CC-86E0-DC6B22D5CB38Q55669321-139594C4-8CC2-4E17-B82F-13AA75B165BCQ57815427-B0FFDB60-3522-4A3F-98D6-4721C7C86EB1
P2860
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@ast
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@en
type
label
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@ast
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@en
prefLabel
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@ast
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@en
P2093
P2860
P356
P1433
P1476
HuR-targeted nanotherapy in co ...... n and invasion in lung cancer.
@en
P2093
J Panneerselvam
R Muralidharan
P2860
P2888
P304
P356
10.1038/CGT.2015.55
P577
2015-10-23T00:00:00Z